Melior Pharmaceuticals Announces New Scientific Advisory Board Member Dr. John Amatruda, an Expert in the Field of Diabetes and Drug Development to Join Board

Melior Discovery is Awarded Grant from Michael J. Fox Foundation

Melior Recieves Patent Notice for Repositioned Drug Candidate MLR-1023